Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the lymphatic system grow unusually and may spread beyond the lymphatic system. The infection-fighting properties of the lymphocytes are lost, making the person more susceptible to infection. The main treatments used are chemotherapy, followed by radiotherapy or chemotherapy alone. Generally surgery is not used as a treatment for the condition.
Scope of the Report:
This report studies the Hodgkin's Lymphoma Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hodgkin's Lymphoma Therapeutics market by product type and applications/end industries.
The Hodgkin’s lymphoma therapeutics pipeline is expected to witness considerable growth in the coming years as the researchers are making novel drug delivery system for the treatment for cancer. The government agencies such as National Cancer Institute and American Cancer Society are supporting the growth of the Hodgkin’s lymphoma (HL) therapeutics pipeline by providing funding, designations and grants for speeding up the drug development process. High prevalence of cancer, increasing awareness regarding cancer treatment, technological advancements and high demand for safe and effect ...
Table of Contents
1 Hodgkin's Lymphoma Therapeutics Market Overview
1.1 Product Overview and Scope of Hodgkin's Lymphoma Therapeutics
1.2 Classification of Hodgkin's Lymphoma Therapeutics by Types
1.2.1 Global Hodgkin's Lymphoma Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Hodgkin's Lymphoma Therapeutics Revenue Market Share by Types in 2017
1.2.3 Alkylating Antineoplastic Agents
1.2.4 Antibiotic Antineoplastic Agents
1.2.5 Antineoplastics Vinca Alkaloid Agents
1.2.6 Podophyllotoxin Derivative Antineoplastic Agents
1.2.7 Antimetabolite Antineoplastic Agents
1.2.8 Anthracycline Antineoplastic Agents
1.2.9 Antimicrotubular Antineoplastics
1.3 Global Hodgkin's Lymphoma Therapeutics Market by Application
1.3.1 Global Hodgkin's Lymphoma Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 H ...